Advise Saving Daliresp for SEVERE COPD Patients With Frequent Exacerbations

You'll get questions about when to use Daliresp (roflumilast) to prevent COPD exacerbations.

New evidence suggests that Daliresp decreases exacerbations that require hospitalization by patients with severe COPD on long-acting bronchodilators plus an inhaled corticosteroid.

This works out to one fewer hospitalization for every 24 severe COPD patients on Daliresp for a year.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote